ClassID:

112255

C12N2810/851 - CPC Classification

Classification description:

Vectors comprising a targeting moiety; Vectors comprising as targeting moiety peptide derived from defined protein from vertebrates mammalian from growth factors; from growth regulators

Recent Application in this class:
#1
20240252625
2024-08-01

CO-EXPRESSION OF CONSTRUCTS AND IMMUNOINHIBITORY COMPOUNDS

#2
20240156984
2024-05-16

METHODS OF DELIVERING ANIONIC AGENTS IN VIVO USING NON-VIRAL NANOPARTICLE-BASED DELIVERY SYSTEMS

#3
20210106695
2021-04-15

Methods of delivering anionic agents in vivo using non-viral nanoparticle-based delivery systems

#4
20200147189
2020-05-14

Identification of mutations in herpes simplex virus envelope glycoproteins that enable or enhance vector retargeting to novel non-HSV receptors

#5
20190336616
2019-11-07

Method of making peptide-tagged PEGylated chitosan nanoparticles

#6
20180369416
2018-12-27

Targeted gene delivery to non-phagocytic mammalian cells via bacterially derived intact minicells

#7
20180064826
2018-03-08

NON-VIRAL NANOPARTICLE-BASED DELIVERY SYSTEM

#8
20170189514
2017-07-06

Identification of mutations in herpes simplex virus envelope glycoproteins that enable or enhance vector retargeting to novel non-HSV receptors

#9
20160222409
2016-08-04

Method of targeting gene delivery using viral vectors

#10
20150343092
2015-12-03

Targeted gene delivery to non-phagocytic mammalian cells via bacterially derived intact minicells

#11
20140227226
2014-08-14

Infectivity-enhanced conditionally-replicative adenovirus and uses thereof

#12
20120220492
2012-08-30

Viral Vectors with Improved Properties

#13
20120207711
2012-08-16

INFECTIVITY-ENHANCED CONDITIONALLY-REPLICATIVE ADENOVIRUS AND USES THEREOF

#14
20120164232
2012-06-28

CONSTRUCT COATED WITH VIRUS COAT-CONSTITUTING PROTEIN AND METHOD FOR PRODUCING SAME

#15
20110212530
2011-09-01

Method of targeted gene delivery using viral vectors

#16
20110045583
2011-02-24

Infectivity-enhanced conditionally-replicative adenovirus and uses thereof

#17
20110020901
2011-01-27

Methods of Making Viral Particles Having a Modified Cell Binding Activity and Uses Thereof

#18
20090136451
2009-05-28

Humanised Baculovirus

#19
20080227740
2008-09-18

Compositions and Methods for Elimination of Unwanted Cells

#20
20080226610
2008-09-18

Compositions and Methods for Elimination of Unwanted Cells

#21
20080171027
2008-07-17

Compositions and Methods for Elimination of Unwanted Cells

#22
20080171026
2008-07-17

Compositions and methods for elimination of unwanted cells

#23
20080152689
2008-06-26

DEVICES CONTAINING DNA ENCODING NEUROTROPHIC AGENTS AND RELATED COMPOSITIONS AND METHODS

#24
20080044903
2008-02-21

GENE TRANSFER METHODS

#25
20070237744
2007-10-11

Targeted gene delivery to non-phagocytic mammalian cells via bacterially derived intact minicells

#26
20070020238
2007-01-25

Method of targeted gene delivery using viral vectors

#27
20060292118
2006-12-28

Hollow nanoparticles of protein and drug using the same

#28
20060286545
2006-12-21

Viral vectors with improved properties

#29
20060110361
2006-05-25

Methods of making viral particles having a modified cell binding activity and uses thereof

#30
20060105982
2006-05-18

Non-invasive gene targeting to ocular cells

#31
20060051335
2006-03-09

Compositions and methods for elimination of unwanted cells

#32
20060002893
2006-01-05

Targeted adenovirus vectors for delivery of heterologous genes

#33
20050221289
2005-10-06

Altering viral tropism